Antibody response Epstein-Barr virus-coded nuclear nasopharyngeal carcinoma Specific antibody responses Epstein-Barr virus-coded nuclear Thirty-five sera pretreatment patients nasopharyngeal carcinoma NPC healthy adults response correlation stage overall stage histopathology correlation stage disease serological follow-up study patients correlation change antibody levels clinical progression serology useful marker relative tumor status 